Keeping patients safe: Antibiotic resistance and the role of nurse executives in antibiotic stewardship

Journal of Nursing Administration

Volumn 45, Issue 2, 2015, Pages 67-69

  Manning, Mary Lou ^a   Giannuzzi, Donna ^b  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b Lee Memorial Health System   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; DRUG UTILIZATION; HUMAN; NURSE ADMINISTRATOR; NURSE ATTITUDE; PATIENT SAFETY; PUBLIC HEALTH SERVICE; STANDARDS; UNITED STATES;

ANTI-INFECTIVE AGENTS; CENTERS FOR DISEASE CONTROL AND PREVENTION (U.S.); DRUG RESISTANCE, MICROBIAL; DRUG UTILIZATION; HUMANS; NURSE ADMINISTRATORS; NURSE'S ROLE; PATIENT SAFETY; UNITED STATES;

EID: 84922274184     PISSN: 00020443     EISSN: 15390721     Source Type: Journal    
DOI: 10.1097/NNA.0000000000000159     Document Type: Conference Paper

References (15)

1. MacLeodCM,Daddi G. A sulfapyridinefast strain of Pneumococcus type I. Proc Soc Exp Biol Med. 1939;41:69-71.
2. SpinkWW, Ferris V. Quantitative action of penicillin inhibitor from penicillinresistant strains of Staphylococcus. Science. 1945;102:221-223.
3. Barrett FF, McGehee RF, Finland M. Methicillin-resistant Staphylococcus aureus at Boston City Hospital.N Engl J Med. 1968;279:441-448.
4. Executive orderVcombating antibioticresistant bacteria. http://www.whitehouse .gov/the-press-office/2014/09/18/executiveorder-combating-antibiotic-resistantbacteria. Accessed September 23, 2014.
5. Centers for Disease Control and Prevention. Antibiotic resistance threats in the United States, 2013. http://www.cdc.gov/drugresistance/threat-report-2013/pdf/ar-threats-2013-508.pdf. Accessed September 12, 2014.
6. Centers for Disease Control and Prevention. Vital signs: improving antibiotic use among hospitalized patients. http://www.cdc.gov/mmwr/pdf/wk/mm6309 .pdf. Accessed September 12, 2014.
7. Schultz L, Lowe TJ, Srinivasan A, Nielson D, Pugliese G. Economic impact of redundant antimicrobial therapy in U.S. hospitals. Infect Control Hosp Epidemiol. 2014;35:1229-1235.
8. Dellit TH, Owens RC, McGowan JE, et al. Infectious Disease Society of America and the Society forHealthcare Epidemiology of America guideline for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis. 2007;44:159-177.
9. Centers for Disease Control and Prevention. Core elements of hospital antibiotic stewardship programs. http://www.cdc .gov/getsmart/healthcare/pdfs/coreelements. pdf. Accessed September 13, 2014.
10. Pollack LA, Gould CV, Srinivasan A. If not now, when? Seizing the moment for antibiotic stewardship. Infect Control Hosp Epidemiol. 2013;34:117-118.
11. Hamilton KW, Fishman NO. Antimicrobial stewardship interventions: thinking inside and outside the box. Infect Dis Clin North Am. 2014;28:301-313.
12. Cosgrove. Strategies for improving antimicrobial use and the role of antimicrobial stewardship programs. Clin Infect Dis. 2011;53:S15-S22.
13. Jenkins TC, Knepper BC, Sabel AL, et al. Decreased antibiotic utilization after implementation of a guideline for inpatient cellulitis and cutaneous abscess. Arch Intern Med. 2011;171: 1072-1079.
14. Gilligan PH. Blood culture contamination: a clinical and financial burden. Infect Control Hosp Epidemiol. 2013; 34:22-23.
15. Shrestha NK, Bhaskaran A, Scalera NK, Schmitt SK, Rehm SJ, Gordon SM. Antimicrobial stewardship at transitions of care from hospital to community. Infect Control Hosp Epidemiol. 2012;33: 401-404.